Metabolic interactions of AGE inhibitor pyridoxamine and antioxidant α-lipoic acid following 22 weeks of treatment in obese Zucker rats
- 10 April 2009
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 84 (15-16), 563-568
- https://doi.org/10.1016/j.lfs.2009.01.021
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant α-lipoic acid on insulin resistance in the obese Zucker ratMetabolism, 2008
- Radical-free biology of oxidative stressAmerican Journal of Physiology-Cell Physiology, 2008
- Alterations in soleus muscle gene expression associated with a metabolic endpoint following exercise training by lean and obese Zucker ratsPhysiological Genomics, 2007
- Proposed Mechanisms for the Induction of Insulin Resistance by Oxidative StressAntioxidants and Redox Signaling, 2005
- Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Pyridoxamine Traps Intermediates in Lipid Peroxidation Reactions in VivoOnline Journal of Public Health Informatics, 2003
- The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese ratsKidney International, 2003
- Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in MusclePublished by Elsevier BV ,2002
- Cytosolic and Mitochondrial Systems for NADH- and NADPH-dependent Reduction of α-Lipoic AcidFree Radical Biology & Medicine, 1997
- Alpha-lipoic acid as a biological antioxidantFree Radical Biology & Medicine, 1995